In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 26th, 2005 | 23 | Yes |
Popular Name: Zolpidem Zolpidem
Find On: PubMed — Wikipedia — Google
CAS Numbers: 103188-50-7 , 103188-50-7; 82626-48-0; 99294-93-6 , 3283-07-6 , 82626-48-0 , 959605-90-4 , 99294-93-6
82626-48-0; D08690; Sanval (TN); Zolpidem (INN)
99294-93-6; Ambien (TN); D00706; Intermezzo (TN); Zolpidem tartrate (JP16/USAN)
Ambien;Hypnogen;Myslee;Stilnoct;Stilnox;Zolpidem Ambien;Zolpidem tartrate
CPD000469145; SAM001246549; ZOLPIDEM TARTRATE
CPD000469145; ZOLPIDEM TARTRATE
Imidazo(1,2-a)pyridine-3-acetamide, 2-(4-methylphenyl)-N,N,6-trimethyl-
Imidazo(1,2-a)pyridine-3-acetamide, N,N,6-trimethyl-2-(4-methylphenyl)-
imidazo[1,2-a]pyridine-3-acetamide,n,n,6-trimethyl-2-(4-methylphenyl)-
N,N,6-Trimethyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-3-acetamide
N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide
N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide; Zolpidem
N,N,6-trimethyl-2-(4-methylphenyl)imidazo(1,2a)pyridine-3-acetamide hemitartrate
N,N,6-Trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide
N,N,N',N'-Tetrakis(4-aminophenyl)-1,4-benzenediamine
N,N-Dimethyl-2-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)acetamide 2,3-dihydroxysuccinate
N,N-Dimethyl-2-(6-methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-acetamide
N,N-Dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.15 | 10.38 | -16.93 | 0 | 4 | 0 | 38 | 307.397 | 3 | ↓ |
Mid Mid (pH 6-8) | 3.15 | 10.86 | -27.89 | 1 | 4 | 1 | 39 | 308.405 | 3 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
biological_use | Hypnotic used for the short-term treatment of insomnia and some brain disorders | ZereneX Building Blocks |
ALOGPS_SOLUBILITY | 3.13e-02 g/l | DrugBank-approved |
mechanism | Benzodiazepine (type I) receptor agonist | ZereneX Building Blocks |
biological_use | Hypnotic used for the short-term treatment of insomnia and some brain disorders | IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP01500z; .5 tartaric acid | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP01500z; SALT: .5 tartaric acid | NIH Clinical Collection via PubChem |
Therapy | sedative, hypnotic | SMDC Iconix |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GBRA1-1-E | GABA Receptor Alpha-1 Subunit (cluster #1 Of 8), Eukaryotic | Eukaryotes | 50 | 0.44 | Binding ≤ 10μM |
GBRA2-1-E | GABA Receptor Alpha-2 Subunit (cluster #1 Of 8), Eukaryotic | Eukaryotes | 737 | 0.37 | Binding ≤ 10μM |
GBRA3-1-E | GABA Receptor Alpha-3 Subunit (cluster #1 Of 8), Eukaryotic | Eukaryotes | 975 | 0.37 | Binding ≤ 10μM |
GBRA4-1-E | GABA Receptor Alpha-4 Subunit (cluster #1 Of 7), Eukaryotic | Eukaryotes | 76 | 0.43 | Binding ≤ 10μM |
GBRA5-1-E | GABA Receptor Alpha-5 Subunit (cluster #1 Of 8), Eukaryotic | Eukaryotes | 35 | 0.45 | Binding ≤ 10μM |
GBRA6-2-E | GABA Receptor Alpha-6 Subunit (cluster #2 Of 8), Eukaryotic | Eukaryotes | 980 | 0.37 | Binding ≤ 10μM |
GBRB2-1-E | GABA Receptor Beta-2 Subunit (cluster #1 Of 7), Eukaryotic | Eukaryotes | 980 | 0.37 | Binding ≤ 10μM |
GBRB3-1-E | GABA Receptor Beta-3 Subunit (cluster #1 Of 6), Eukaryotic | Eukaryotes | 383 | 0.39 | Binding ≤ 10μM |
GBRG2-1-E | GABA Receptor Gamma-2 Subunit (cluster #1 Of 7), Eukaryotic | Eukaryotes | 980 | 0.37 | Binding ≤ 10μM |
GBRG3-2-E | GABA Receptor Gamma-3 Subunit (cluster #2 Of 7), Eukaryotic | Eukaryotes | 383 | 0.39 | Binding ≤ 10μM |
TSPO-1-E | Peripheral-type Benzodiazepine Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4700 | 0.32 | Binding ≤ 10μM |
Z104301-1-O | GABA-A Receptor; Anion Channel (cluster #1 Of 8), Other | Other | 48 | 0.45 | Binding ≤ 10μM |
Z104301-1-O | GABA-A Receptor; Anion Channel (cluster #1 Of 2), Other | Other | 48 | 0.45 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GBRA1_RAT | P62813 | GABA Receptor Alpha-1 Subunit, Rat | 125 | 0.42 | Binding ≤ 1μM |
GBRA1_HUMAN | P14867 | GABA Receptor Alpha-1 Subunit, Human | 130 | 0.42 | Binding ≤ 1μM |
GBRA2_RAT | P23576 | GABA Receptor Alpha-2 Subunit, Rat | 156 | 0.41 | Binding ≤ 1μM |
GBRA2_HUMAN | P47869 | GABA Receptor Alpha-2 Subunit, Human | 103 | 0.43 | Binding ≤ 1μM |
GBRA3_RAT | P20236 | GABA Receptor Alpha-3 Subunit, Rat | 383 | 0.39 | Binding ≤ 1μM |
GBRA3_HUMAN | P34903 | GABA Receptor Alpha-3 Subunit, Human | 246 | 0.40 | Binding ≤ 1μM |
GBRA4_RAT | P28471 | GABA Receptor Alpha-4 Subunit, Rat | 76 | 0.43 | Binding ≤ 1μM |
GBRA5_RAT | P19969 | GABA Receptor Alpha-5 Subunit, Rat | 35 | 0.45 | Binding ≤ 1μM |
GBRA6_RAT | P30191 | GABA Receptor Alpha-6 Subunit, Rat | 125 | 0.42 | Binding ≤ 1μM |
GBRB2_RAT | P63138 | GABA Receptor Beta-2 Subunit, Rat | 125 | 0.42 | Binding ≤ 1μM |
GBRB2_HUMAN | P47870 | GABA Receptor Beta-2 Subunit, Human | 46.3 | 0.45 | Binding ≤ 1μM |
GBRB3_HUMAN | P28472 | GABA Receptor Beta-3 Subunit, Human | 103 | 0.43 | Binding ≤ 1μM |
GBRB3_RAT | P63079 | GABA Receptor Beta-3 Subunit, Rat | 156 | 0.41 | Binding ≤ 1μM |
GBRG2_RAT | P18508 | GABA Receptor Gamma-2 Subunit, Rat | 125 | 0.42 | Binding ≤ 1μM |
GBRG2_HUMAN | P18507 | GABA Receptor Gamma-2 Subunit, Human | 103 | 0.43 | Binding ≤ 1μM |
GBRG3_RAT | P28473 | GABA Receptor Gamma-3 Subunit, Rat | 156 | 0.41 | Binding ≤ 1μM |
Z104301 | Z104301 | GABA-A Receptor; Anion Channel | 25 | 0.46 | Binding ≤ 1μM |
GBRA1_RAT | P62813 | GABA Receptor Alpha-1 Subunit, Rat | 125 | 0.42 | Binding ≤ 10μM |
GBRA1_HUMAN | P14867 | GABA Receptor Alpha-1 Subunit, Human | 130 | 0.42 | Binding ≤ 10μM |
GBRA2_HUMAN | P47869 | GABA Receptor Alpha-2 Subunit, Human | 103 | 0.43 | Binding ≤ 10μM |
GBRA2_RAT | P23576 | GABA Receptor Alpha-2 Subunit, Rat | 156 | 0.41 | Binding ≤ 10μM |
GBRA3_HUMAN | P34903 | GABA Receptor Alpha-3 Subunit, Human | 1850 | 0.35 | Binding ≤ 10μM |
GBRA3_RAT | P20236 | GABA Receptor Alpha-3 Subunit, Rat | 383 | 0.39 | Binding ≤ 10μM |
GBRA4_RAT | P28471 | GABA Receptor Alpha-4 Subunit, Rat | 76 | 0.43 | Binding ≤ 10μM |
GBRA5_RAT | P19969 | GABA Receptor Alpha-5 Subunit, Rat | 35 | 0.45 | Binding ≤ 10μM |
GBRA6_RAT | P30191 | GABA Receptor Alpha-6 Subunit, Rat | 125 | 0.42 | Binding ≤ 10μM |
GBRB2_HUMAN | P47870 | GABA Receptor Beta-2 Subunit, Human | 1850 | 0.35 | Binding ≤ 10μM |
GBRB2_RAT | P63138 | GABA Receptor Beta-2 Subunit, Rat | 125 | 0.42 | Binding ≤ 10μM |
GBRB3_RAT | P63079 | GABA Receptor Beta-3 Subunit, Rat | 156 | 0.41 | Binding ≤ 10μM |
GBRB3_HUMAN | P28472 | GABA Receptor Beta-3 Subunit, Human | 103 | 0.43 | Binding ≤ 10μM |
GBRG2_RAT | P18508 | GABA Receptor Gamma-2 Subunit, Rat | 125 | 0.42 | Binding ≤ 10μM |
GBRG2_HUMAN | P18507 | GABA Receptor Gamma-2 Subunit, Human | 103 | 0.43 | Binding ≤ 10μM |
GBRG3_RAT | P28473 | GABA Receptor Gamma-3 Subunit, Rat | 156 | 0.41 | Binding ≤ 10μM |
Z104301 | Z104301 | GABA-A Receptor; Anion Channel | 25 | 0.46 | Binding ≤ 10μM |
TSPO_RAT | P16257 | Peripheral-type Benzodiazepine Receptor, Rat | 4700 | 0.32 | Binding ≤ 10μM |
Z104301 | Z104301 | GABA-A Receptor; Anion Channel | 48 | 0.45 | Functional ≤ 10μM |
Description | Species |
---|---|
GABA A receptor activation | |
Ligand-gated ion channel transport |
No pre-computed analogs available. Try a structural similarity search.